.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cell-free DNA screening has transformed prenatal screening for common fetal aneuploidies because of its high sensitivity, particularly for trisomy 21. Meta-analyses and prospective studies show substantially higher detection rates and lower false-positive rates than traditional serum screening for several common chromosomal conditions. For clinicians, the important point is that cell-free DNA is a screening test, not a diagnostic test. Positive results require genetic counseling and confirmation with invasive diagnostic testing such as chorionic-villus sampling or amniocentesis before irreversible decisions. The pretest probability also affects positive predictive value, so counseling should incorporate maternal age, ultrasound findings and the screened condition. In twin or atypical pregnancies, test performance can differ and specialist input becomes particularly important. NIPT therefore fits best into a structured prenatal pathway combining informed consent, ultrasound assessment, screening interpretation and access to diagnostic testing.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Cell-free DNA screening has transformed prenatal screening for common fetal aneuploidies because of its high sensitivity, particularly for trisomy 21. Meta-analyses and prospective studies show substantially higher detection rates and lower false-positive rates than traditional serum screening for several common chromosomal conditions. For clinicians, the important point is that cell-free DNA is a screening test, not a diagnostic test. Positive results require genetic counseling and confirmation with invasive diagnostic testing such as chorionic-villus sampling or amniocentesis before irreversible decisions. The pretest probability also affects positive predictive value, so counseling should incorporate maternal age, ultrasound findings and the screened condition. In twin or atypical pregnancies, test performance can differ and specialist input becomes particularly important. NIPT therefore fits best into a structured prenatal pathway combining informed consent, ultrasound assessment, screening interpretation and access to diagnostic testing.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
